Salivary gland cancer in Southern Brazil: a prognostic study of 107 cases

• Published in: Medicina oral, patología oral y cirugía bucal Vol. 26; no. 3; pp. e393 - e403
• Main Authors: Zanella, V-G, Wagner, V-P, Schmidt, T-R, Thieme, S, Correa, C, Fonseca, F-P, Rigon, P, Barra, M-B, Kroef, R-G, Vargas, P-A, Martins, M-D
• Format: Journal Article
• Language: English
• Published: Spain Medicina Oral S.L 01-05-2021
• Subjects: Brazil - epidemiology; Dentistry; Humans; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salivary Gland Neoplasms - diagnosis; Salivary Gland Neoplasms - epidemiology; Salivary Gland Neoplasms - therapy; Brazil
• ISSN: 1698-6946; 1698-4447; 1698-6946
• DOI: 10.4317/medoral.24248

Salivary gland cancers (SGC) represent an uncommon group of heterogeneous tumors. We performed a retrospective survey of SGC diagnosed in a reference center for treatment of malignant tumors from the south of Brazil aiming to determine the prognostic value of demographic, clinic and pathologic features.
Cases diagnosed as SGC between 2006 and 2016 were retrospectively collected. Medical records were examined to extract demographic, clinic, pathologic and follow-up information.
One-hundred and seven cases of SGC were identified. The most common SGC were mucoepidermoid carcinoma (MEC) (n = 39) followed by adenoid cystic carcinoma (AdCC) (n = 29). Among AdCCs, 55.2% of cases were classified as cribriform, 27.6% as tubular and 17.2% as solid. The tubular subtype had the highest percentage of cases with perineural invasion (p=0.01). Among MEC, 61.5% of cases were classified as low grade, 15.4% as intermediate grade and 19.9% as high grade. Low grade MEC had the lowest percentage of cases with perineural invasion (p=0.04). The 5-year survival for loco-regional control, disease-free survival (DFS) and disease-specific survival were 75%, 70% and 84%, respectively. The following features were associated with poor DFS: advanced age (p=0.03), rural residency (p=0.01), being a smoker or former smoker (p=0.01), pain (p=0.03), nodal metastasis (p<0.001), need for chemotherapy (p=0.02), neck dissection (p=0.04), perineural invasion (p=0.01), and being diagnosed with AdCC compared to MEC (p=0.02).
The clinco-demographic and pathologic features identified as prognostic factors reveal the profile of patients at increased risk of recurrence and who would benefit from closer follow-up.